However, if confirmed in a large-cohort population, this evidence can provide the scientific rationale for the use of 18F–choline PET/CT analysis as an early predictor of prostate cancer aggressiveness regardless of the PSA value. The gene discussed is KLK3; the disease is prostate cancer.